Levine Cancer Institute-Ballantyne is a clinical research site located in Charlotte, North Carolina, United States 28277.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Levine Cancer Institute-Ballantyne has participated in 29 clinical trials with 25 currently active.
Therapeutic areas: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Levine Cancer Institute-Ballantyne has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Levine Cancer Institute-Ballantyne has 29 clinical trials on record, with 25 currently active. Their work covers Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.
Levine Cancer Institute-Ballantyne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.